Phillipe Bahadoran
Papers
1
Total Citations
30
H-Index
1
About
Philippe Bahadoran is a pioneering oncologist whose work bridges the frontiers of radiation oncology and surgical precision. His primary research focuses on the integration of robotic stereotactic radioablation with neoadjuvant chemotherapy for breast cancer treatment, a field where he has made landmark contributions. His most-cited study, "Robotic Stereotactic Radioablation Concomitant With Neo-Adjuvant Chemotherapy for Breast Tumors" (2009), with 30 citations, introduced a novel paradigm by demonstrating the feasibility and safety of combining high-dose, precisely targeted radiation with pre-surgical chemotherapy. This work has helped reshape treatment protocols, offering patients a less invasive yet highly effective option that may reduce tumor burden before surgery. Bahadoran’s research is notable for its translational impact, directly influencing clinical practice in breast oncology. His achievements reflect a commitment to advancing multimodal therapies, and his findings continue to guide subsequent investigations into stereotactic body radiation therapy (SBRT) for early-stage breast cancer. For students and researchers, Bahadoran’s work exemplifies how innovative technology can be harnessed to improve oncologic outcomes.
Research Focus
Key Achievements
Top Papers
- 1